A new framework for the diagnosis of Alzheimer's disease

Lancet Neurology

Volumn 6, Issue 8, 2007, Pages 667-669

  Foster, Norman L ^a  

^a Imaging and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; AMNESIA; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; FRONTOTEMPORAL DEMENTIA; GENETIC SCREENING; HUMAN; LETTER; MEMORY DISORDER; NEUROIMAGING; PRIORITY JOURNAL; PSYCHOMETRY;

ALZHEIMER DISEASE; DEMENTIA; DISEASE PROGRESSION; HUMANS;

EID: 34447299385     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70179-5     Document Type: Letter

References (8)

1. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
2. Tierney M., Fisher R., Lewis A., et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38 (1988) 359-364
3. Morris J., McKeel D., Fulling K., Torack R., and Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 24 (1988) 17-22
4. Dubois B., Feldman F., Jacova C., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6 (2007) 734-746
5. Varma A., Snowden J., Lloyd J., Talbot P., Mann D., and Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 66 (1999) 184-188
6. Jicha G., Parisi J., Dickson D., et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 63 (2006) 674-681
7. Jelic V., Kivipelto M., and Winblad B. Clinical trials in mild cognitive impairment: lessons for the future. J Neurol Neurosurg Psychiatry 77 (2006) 429-438
8. Frank R., Galasko D., Hampel H., et al. Biological markers for therapeutic trials in Alzheimer's disease: proceedings of the Biological Markers Working Group, NIA initiative on Neuroimaging in Alzheimer's Disease. Neurobiol Aging 24 (2003) 521-536